Iranian Comprehensive Haemophilia Care Centre, Tehran, Islamic Republic of Iran.
Thromb Haemost. 2012 Nov;108(5):946-54. doi: 10.1160/TH12-04-0189. Epub 2012 Sep 26.
Platelet-type von Willebrand disease (PT-VWD) is a rare bleeding disorder with an intrinsic defect in platelets rather than von Willebrand factor (VWF), but has clinical and laboratory features similar to the more common type 2B VWD. The intriguing nature of the pathophysiology and molecular genetics of PT-VWD has created lengthy debate in literature regarding its discrimination from type 2B VWD, and essentially confirming DNA analysis as the gold standard in diagnosis and revealing pathologic mutations. In this report we identify a novel Asp235Tyrmutation in the GP1BA gene of two Iranian patients showing the PT-VWD phenotype who were originally misdiagnosed as type 2B VWD. By structural modelling of the mutant by introducing Tyr235 into the available crystal structure of the glycoprotein (GP)Ibα N-terminal domain, we observed the mutant Tyr235 generates a hydrophobic tip to the extended β-switch loop of GPIbα. Further modelling of the resulting complex with VWFA1 indicates this could result in an enhanced interface compared to wild-type Asp235. This data provides an update to the present knowledge about this rare disorder, and confirms the necessity of genetic testing for accurate diagnosis, and the importance of studying natural mutations to better understand molecular aspects of GPIbα-VWFA1 interaction.
血小板型血管性血友病(PT-VWD)是一种罕见的出血性疾病,其血小板内存在固有缺陷,而非血管性血友病因子(VWF),但其临床表现和实验室特征与更为常见的 2B 型 VWD 相似。PT-VWD 的病理生理学和分子遗传学的性质非常有趣,这在文献中引发了关于其与 2B 型 VWD 相区分的长时间争论,并最终确认 DNA 分析是诊断的金标准,并揭示了病理性突变。在本报告中,我们在两名伊朗患者的 GP1BA 基因中发现了一种新的 Asp235Tyr 突变,他们表现出 PT-VWD 表型,但最初被误诊为 2B 型 VWD。通过将 Tyr235 引入可利用的糖蛋白(GP)Ibα N 末端结构域的晶体结构中,对突变体进行结构建模,我们观察到突变的 Tyr235 生成了一个延伸的β-开关环的疏水性尖端到 GPIbα。与 VWFA1 进一步建模表明,与野生型 Asp235 相比,这可能导致增强的界面。该数据为这一罕见疾病的现有知识提供了更新,并证实了遗传测试对于准确诊断的必要性,以及研究天然突变以更好地理解 GPIbα-VWFA1 相互作用的分子方面的重要性。